Promising Penny Stocks To Consider In August 2026

Over the last 7 days, the market has dropped 2.1%, but it is up 19% over the past year, with earnings expected to grow by 17% annually in the coming years. Penny stocks may be a throwback term, but they represent opportunities for growth at lower price points, especially when combined with strong balance sheets and solid fundamentals. This article explores several penny stocks that stand out as hidden gems with potential for impressive returns.

Here we highlight a subset of our preferred stocks from the screener.

AC Immune (ACIU)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: AC Immune SA is a clinical-stage biopharmaceutical company focused on discovering, designing, and developing medicines and diagnostic products for neurodegenerative diseases linked to protein misfolding, with a market cap of $256.52 million.

Operations: The company generates revenue of CHF 17.51 million from its segment dedicated to the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases.

Market Cap: $256.52M

AC Immune's recent FDA Fast Track designation for its anti-alpha-synuclein immunotherapy, ACI-7104, marks a significant milestone in its Parkinson’s disease research. Despite being unprofitable with a negative return on equity of -122.71%, the company has reduced losses over five years and reported CHF 16.23 million in revenue for H1 2026, up from CHF 2.3 million the previous year. The company benefits from a strong cash position relative to long-term liabilities and is debt-free. However, short-term liabilities exceed short-term assets by CHF 6.8 million, indicating potential liquidity challenges ahead.

• Click to explore a detailed breakdown of our findings in AC Immune's financial health report.
• Gain insights into AC Immune's outlook and expected performance with our report on the company's earnings estimates.

Xtra-Gold Resources (XTGR.F)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Xtra-Gold Resources Corp. is a gold exploration company operating in Ghana with a market cap of $101.06 million.

Operations: The company has not reported any revenue segments.

Market Cap: $101.06M

Xtra-Gold Resources, a gold exploration company in Ghana, remains pre-revenue but has shown impressive earnings growth of 40.2% annually over the past five years. The company reported net income of US$1.2 million for Q2 2026, doubling from the previous year, with stable earnings per share growth. Its seasoned management and board contribute to strategic stability, while a strong balance sheet is evident with short-term assets of US$18.7 million far exceeding liabilities at US$1.5 million. Importantly, Xtra-Gold is debt-free and maintains high return on equity at 23.5%, underscoring its financial resilience in the volatile mining sector.

• Take a closer look at Xtra-Gold Resources' potential here in our financial health report.
• Learn about Xtra-Gold Resources' historical performance here.

Zion Oil & Gas (ZNOG)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Zion Oil & Gas, Inc. is an oil and gas exploration company operating in Israel with a market cap of $488.37 million.

Operations: Currently, the company does not report any revenue segments.

Market Cap: $488.37M

Zion Oil & Gas operates in Israel and is pre-revenue, with no significant revenue lines reported. The company recently announced a net loss of US$2.05 million for Q2 2026, an increase from the previous year. Despite being unprofitable, Zion has reduced its losses over five years by 17.7% annually and maintains a debt-free status with short-term assets of US$13.1 million surpassing liabilities. Operations have commenced on the Megiddo-Jezreel #2 well sidetrack phase, supported by experienced management and board members averaging ten years in tenure, although cash runway remains under one year if current free cash flow persists.

• Dive into the specifics of Zion Oil & Gas here with our thorough balance sheet health report.
• Examine Zion Oil & Gas' past performance report to understand how it has performed in prior years.

Taking Advantage

• Click this link to deep-dive into the 318 companies within our US Penny Stocks screener.
• Ready To Venture Into Other Investment Styles? Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com